SCHEMBL573278

SCHEMBL573278

COC(=O)c1cc(N)c(Oc2ccccc2)c(S(=O)(=O)N(C)C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
HPGD P15428 6/20 0.48
KDM4E B2RXH2 4/20 0.48
GAA P10253 3/20 0.48
PKM P14618 1/20 0.48
USP2 O75604 3/20 0.42
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
LMNA P02545 4/20 0.42
HSD17B10 Q99714 3/20 0.40
TSHR P16473 3/20 0.40
HIF1A Q16665 2/20 0.40
CA2 P00918 1/20 0.40
BLM P54132 1/20 0.40
SLC12A2 P55011 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
KCNJ6 P48051 2/20 0.39
KCNJ5 P48544 2/20 0.39
KCNJ3 P48549 2/20 0.39
RAB9A P51151 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11852517 0.89 LMNA (0.47) ALDH1A1HPGDKDM4EGAAPKM
SCHEMBL14879659 0.86 ALDH1A1 (0.51) ALDH1A1HPGDKDM4EGAAPKM
SCHEMBL2875469 0.86 HPGD (0.52) ALDH1A1HPGDKDM4EGAAPKM
SCHEMBL11546751 0.84 ALDH1A1 (0.49) ALDH1A1HPGDKDM4EGAAPKM
SCHEMBL11545452 0.83 USP2 (0.54) ALDH1A1HPGDKDM4EGAAPKM
SCHEMBL574175 0.82 HPGD (0.43) ALDH1A1HPGDKDM4EGAAPKM
SCHEMBL573731 0.82 HPGD (0.43) ALDH1A1HPGDKDM4EGAAPKM
SCHEMBL573529 0.82 VCAM1 (0.51) ALDH1A1HPGDGAAMAPTSMN1; SMN2
SCHEMBL573942 0.79 KDM4E (0.66) ALDH1A1HPGDKDM4EUSP2LMNA
SCHEMBL573803 0.79 ALDH1A1 (0.48) ALDH1A1HPGDKDM4EUSP2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 WO disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 WO disclosed